STOCK TITAN

Barclays Appoints Kieran Whitty as a Co-Head of Healthcare for Europe, Middle East and Africa

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management

Barclays (BCS) has announced the appointment of Kieran Whitty as Co-Head of Healthcare EMEA, partnering with Sid Chhibbar. This strategic appointment aims to strengthen Barclays' investment banking presence in the UK and Continental Europe.

Whitty joins from Bank of America, where he served 18 years, most recently as Managing Director in EMEA Healthcare. His expertise spans healthcare services and medtech, with notable transactions including advising PureHealth on Hellenic Healthcare Group acquisition and Nordic Capital on Sunrise Medical exit.

The appointment reinforces Barclays' healthcare practice, with Whitty scheduled to start in June, based in London, reporting to Richard Landgarten, Global Head of Healthcare and Real Estate Investment Banking.

Barclays (BCS) ha annunciato la nomina di Kieran Whitty come Co-Responsabile del Settore Sanitario per l'EMEA, in collaborazione con Sid Chhibbar. Questa nomina strategica mira a rafforzare la presenza di Barclays nel settore dell'investment banking nel Regno Unito e in Europa continentale.

Whitty proviene da Bank of America, dove ha lavorato per 18 anni, ricoprendo recentemente il ruolo di Direttore Generale nel Settore Sanitario per l'EMEA. La sua esperienza copre i servizi sanitari e la tecnologia medica, con transazioni significative come la consulenza a PureHealth nell'acquisizione del Gruppo Sanitario Ellenico e a Nordic Capital nell'uscita da Sunrise Medical.

La nomina rafforza la pratica sanitaria di Barclays, con Whitty che inizierà a giugno, basato a Londra e riferendo a Richard Landgarten, Responsabile Globale del Settore Sanitario e dell'Investment Banking Immobiliare.

Barclays (BCS) ha anunciado el nombramiento de Kieran Whitty como Co-Director de Salud EMEA, en colaboración con Sid Chhibbar. Este nombramiento estratégico tiene como objetivo fortalecer la presencia de Barclays en la banca de inversión en el Reino Unido y en Europa Continental.

Whitty se une desde Bank of America, donde trabajó durante 18 años, siendo su último cargo el de Director General en Salud EMEA. Su experiencia abarca servicios de salud y tecnología médica, con transacciones destacadas que incluyen asesorar a PureHealth en la adquisición del Grupo de Salud Helenico y a Nordic Capital en la salida de Sunrise Medical.

El nombramiento refuerza la práctica de salud de Barclays, con Whitty programado para comenzar en junio, con sede en Londres, reportando a Richard Landgarten, Jefe Global de Salud y Banca de Inversión Inmobiliaria.

바클레이스 (BCS)키어런 휘티를 EMEA 헬스케어 공동 책임자로 임명했다고 발표했습니다. 시드 치바르와 협력하여 이 전략적 임명은 바클레이스의 영국 및 유럽 대륙에서의 투자은행 존재감을 강화하는 것을 목표로 하고 있습니다.

휘티는 뱅크 오브 아메리카에서 18년 동안 근무했으며, 최근에는 EMEA 헬스케어 부문의 전무 이사로 재직했습니다. 그의 전문성은 헬스케어 서비스와 메드텍에 걸쳐 있으며, PureHealth의 헬레닉 헬스케어 그룹 인수 및 Nordic Capital의 선라이즈 메디컬 퇴출에 대한 자문을 포함한 주목할 만한 거래가 있습니다.

이번 임명은 바클레이스의 헬스케어 실무를 강화하며, 휘티는 6월에 런던에서 근무를 시작하고, 글로벌 헬스케어 및 부동산 투자은행 책임자인 리차드 랜드가르텐에게 보고할 예정입니다.

Barclays (BCS) a annoncé la nomination de Kieran Whitty en tant que Co-Responsable du secteur de la santé EMEA, en partenariat avec Sid Chhibbar. Cette nomination stratégique vise à renforcer la présence de Barclays dans le secteur de la banque d'investissement au Royaume-Uni et en Europe continentale.

Whitty rejoint Barclays après 18 ans passés à Bank of America, où il a récemment occupé le poste de Directeur Général dans le secteur de la santé EMEA. Son expertise couvre les services de santé et la technologie médicale, avec des transactions notables telles que le conseil à PureHealth pour l'acquisition du Groupe de Santé Hellénique et à Nordic Capital pour la sortie de Sunrise Medical.

Cette nomination renforce la pratique de la santé de Barclays, Whitty devant commencer en juin, basé à Londres et rendant compte à Richard Landgarten, Responsable Mondial de la Santé et de la Banque d'Investissement Immobilier.

Barclays (BCS) hat die Ernennung von Kieran Whitty zum Co-Leiter des Gesundheitssektors EMEA bekannt gegeben, in Partnerschaft mit Sid Chhibbar. Diese strategische Ernennung zielt darauf ab, die Investmentbanking-Präsenz von Barclays im Vereinigten Königreich und in Kontinentaleuropa zu stärken.

Whitty kommt von der Bank of America, wo er 18 Jahre tätig war, zuletzt als Geschäftsführer im Gesundheitswesen EMEA. Sein Fachwissen umfasst Gesundheitsdienstleistungen und Medizintechnologie, mit bemerkenswerten Transaktionen wie der Beratung von PureHealth beim Erwerb der Hellenic Healthcare Group und Nordic Capital beim Ausstieg von Sunrise Medical.

Die Ernennung stärkt die Gesundheitsabteilung von Barclays, wobei Whitty im Juni beginnen soll, mit Sitz in London und Berichterstattung an Richard Landgarten, Global Head of Healthcare und Real Estate Investment Banking.

Positive
  • Strategic expansion of healthcare division with experienced industry veteran
  • Enhanced capabilities in healthcare services and medtech sectors
  • Strengthened presence in key UK and Continental Europe markets
Negative
  • None.

LONDON--(BUSINESS WIRE)-- Barclays today announces the appointment of Kieran Whitty as Co-Head of Healthcare EMEA (Europe, Middle East and Africa), working alongside Sid Chhibbar, Co-Head of Healthcare EMEA.

This appointment reflects Barclays’ effort to continue its growth in the UK and Continental Europe, which is a key focus for Barclays investment bank.

Kieran joins Barclays from Bank of America where he spent 18 years, most recently as a Managing Director in the EMEA Healthcare team. He has a strong track record advising clients, with extensive experience and connections across the healthcare sector, specifically in the healthcare services and medtech space, working with corporates and sponsors. He recently advised PureHealth on its acquisition of Hellenic Healthcare Group and Nordic Capital on its exit from Sunrise Medical.

Kieran will work alongside Sid Chhibbar, who joined Barclays in 2015 and advises corporates and financial sponsors across the healthcare sector with a focus on Pharma and Pharma Services.

“Kieran’s extensive industry expertise and his proven track record in helping clients will be hugely complementary to our already strong healthcare practice,” said Richard Landgarten, Global Head of Healthcare and Real Estate. “We are delighted to be able to provide clients with expanded capabilities to support their growth.”

“Kieran’s appointment demonstrates our continued investment in senior talent and our commitment to helping clients,” said Alisdair Gayne, Co-Head of Investment Banking, EMEA. “It underlines the investment in our EMEA franchise to deepen relationships with our clients, whilst driving growth and delivering returns for our shareholders.”

Kieran joins in June and will be based in London, reporting to Richard Landgarten, Global Head of Healthcare and Real Estate Investment Banking.

About Barclays
Our vision is to be the UK-centred leader in global finance. We are a diversified bank with comprehensive UK consumer, corporate and wealth and private banking franchises, a leading investment bank and a strong, specialist US consumer bank. Through these five divisions, we are working together for a better financial future for our customers, clients and communities. For further information about Barclays, please visit our website home.barclays.

Press Contacts:

James White (UK)

+44 (0)20 7773 1782

james.xa.white@barclays.com

Source: Barclays

FAQ

What is the significance of Kieran Whitty's appointment to Barclays (BCS) healthcare division?

Whitty's appointment as Co-Head of Healthcare EMEA strengthens Barclays' investment banking presence in UK and Europe, bringing 18 years of healthcare sector expertise from Bank of America.

What are Kieran Whitty's notable achievements before joining Barclays (BCS)?

At Bank of America, Whitty advised PureHealth on Hellenic Healthcare Group acquisition and Nordic Capital on Sunrise Medical exit, specializing in healthcare services and medtech.

When will Kieran Whitty start his role at Barclays (BCS) and who will he report to?

Whitty will start in June, based in London, reporting to Richard Landgarten, Global Head of Healthcare and Real Estate Investment Banking.

How does this appointment align with Barclays' (BCS) strategic goals?

The appointment reflects Barclays' commitment to growth in UK and Continental Europe, expanding capabilities to support clients and deliver shareholder returns.
Barclays

NYSE:BCS

BCS Rankings

BCS Latest News

BCS Stock Data

55.61B
3.59B
0.01%
6.92%
0.34%
Banks - Diversified
Financial Services
Link
United Kingdom
London